Notice 30 May 2025 compliance, countervailing duties, antidumping, financial assistance, domestic producers, us customs and border protection

💰Notice on Distribution of Continued Dumping Offsets for 2025

Pursuant to the Continued Dumping and Subsidy Offset Act of 2000, this document is U.S. Customs and Border Protection's (CBP) notice of intent to distribute assessed antidumping and countervailing duties (known as the continued dumping and subsidy offset) for Fiscal Year 2025 in connection with countervailing duty orders, antidumping duty orders, and findings under the Antidumping Act of 1921. This document provides the instructions for affected domestic producers, or anyone alleging eligibility to receive a distribution, to file certifications to claim a distribution in relation to the listed orders and findings, and to provide CBP with the necessary information to effect payment of a distribution by electronic funds transfer.

Learn More
Rule 30 May 2025 compliance, agriculture, regulations, usda, imports, administrative practice and procedure, reporting and recordkeeping requirements, tobacco, advisory committees, inspections, pesticides and pests, government publications

📉USDA Updates Tobacco Grading and Inspections Regulations

This direct final rule amends regulations that govern tobacco price support services established under the Agricultural Act of 1949. The Fair and Equitable Tobacco Reform Act of 2004 eliminated the price support and quota system for tobacco produced in the United States. In alignment with Executive Order 14192, AMS is removing and, where appropriate, amending regulations that have expired authorizing statutes and govern non-operational programs.

Learn More
Notice 30 May 2025 compliance, regulation, fda, public health, drug importation, legal consequences

🚫FDA Issues 5-Year Debarment Order Against Evan Asher Field

The Food and Drug Administration (FDA) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Evan Asher Field for a period of 5 years from importing or offering for import any drug into the United States. FDA bases this order on a finding that Mr. Field was convicted of one felony count under Federal law. The factual basis supporting Mr. Field's conviction, as described below, is conduct relating to the importation into the United States of a drug or controlled substance. Mr. Field was given notice of the proposed debarment and was given an opportunity to request a hearing to show why he should not be debarred. As of April 25, 2024 (30 days after receipt of the notice), Mr. Field had not responded. Mr. Field's failure to respond and request a hearing constitutes a waiver of his right to a hearing concerning this matter.

Learn More
Proposed Rule 30 May 2025 compliance, regulations, transportation, construction, federal aid, appalachian contracts

🛣️FHWA Proposes to Rescind Federal-Aid Contract Requirements

FHWA is proposing to rescind the rule and regulations issued on September 30, 1974, Federal-Aid Contracts (Appalachian Contracts).

Learn More
Proposed Rule 30 May 2025 compliance, transportation, motor carriers, motor vehicle safety, dot, highway safety, fuel regulations

⛽Proposed Changes to Fuel Tank Overfill Regulations by FMCSA

FMCSA proposes to remove the requirement in the Federal Motor Carrier Safety Regulations (FMCSRs) that a liquid fuel tank manufactured on or after January 1, 1973, be designed and constructed so that it cannot be filled, in a normal filling operation, with a quantity of fuel that exceeds 95 percent of the tank's liquid capacity. This proposal is in response to a petition for rulemaking from the Commercial Vehicle Safety Alliance (CVSA). The proposed change would remove an unnecessary and outdated requirement from the FMCSRs.

Learn More
Notice 30 May 2025 compliance, information collection, regulation, department of defense, businesses, veteran organizations

🎖️Proposed Information Collection for Vietnam War Commemoration Program

In compliance with the Paperwork Reduction Act of 1995, the WHS announces a proposed public information collection and seeks public comment on the provisions thereof. Comments are invited on: whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; the accuracy of the agency's estimate of the burden of the proposed information collection; ways to enhance the quality, utility, and clarity of the information to be collected; and ways to minimize the burden of the information collection on respondents, including through the use of automated collection techniques or other forms of information technology.

Learn More
Rule 30 May 2025 compliance, transportation, motor carriers, federal regulations, administrative practice and procedure, fmcsa, freight forwarders, highways and roads, motor carrier regulations

🚚FMCSA Repeals Obsolete Motor Carrier Routing Regulations

FMCSA repeals the for-hire motor carrier routing regulations which concern servicing municipalities and unincorporated communities. These regulations are unlawful because they exceed FMCSA's statutory authority following the transfer of rules from the Interstate Commerce Commission (ICC) to the Federal Highway Administration (FHWA) in 1995, which were carried over to FMCSA in 2000.

Learn More
Notice 30 May 2025 compliance, trade, regulation, u.s., foreign affairs, antiterrorism

🚫Countries Not Cooperating with U.S. Antiterrorism Efforts

The Department of State has determined that Cuba, North Korea, Iran, Syria, and Venezuela are not cooperating fully with U.S. antiterrorism efforts. This determination is communicated to Congress and will be published in the Federal Register, affecting international relations and potential business dealings with these nations.

Learn More
Notice 30 May 2025 compliance, regulations, employment, reasonable accommodations, disabilities, merit systems protection board

⚖️MSPB Proposes New Information Collection for Reasonable Accommodations

The U.S. Merit Systems Protection Board (MSPB), as part of its continuing effort to reduce paperwork and respondent burden, intends to request approval of a new information collection from the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. MSPB is submitting this Information Collection Request (ICR), entitled Accommodation Request Form, OMB Control No. 3124-0NEW, for approval in accordance with Federal regulations, and is requesting public comments. This collection was developed as part of MSPB's effort to streamline the process for collecting information from employees and applicants to MSPB, as well as participants in MSPB functions (parties and/or participants in MSPB appeals, respondents to surveys, and all other individuals engaged in activity conducted by the MSPB), who seek a reasonable accommodation in order for MSPB to carry out its functions with respect to these individuals. The purpose of this notice is to allow 30 days for public comment preceding submission of the collection to OMB.

Learn More
Notice 30 May 2025 compliance, regulation, fda, manufacturing, drug products, color additives

🎨FDA Guidance on Replacing Color Additives in Drug Products

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Replacing Color Additives in Approved or Marketed Drug Products." This draft guidance provides recommendations for replacing color additives in approved or marketed drug products. If a color additive is replaced in a drug product, information to support the change should be retained and available at the manufacturing facility. Additionally, this draft guidance recommends that new drug application (NDA) and abbreviated new drug application (ANDA) holders submit information to support color additive replacements in changes being effected in 30 days (CBE-30) supplements. Although a qualitative or quantitative change to an inactive ingredient is generally considered a major change, in many cases, replacing a color additive with one that is listed in the color additive regulations is unlikely to adversely affect the identity, strength, quality, purity, or potency of the drug product. Therefore, this draft guidance recommends a CBE-30 for such a change.

Learn More